Exact Mass: 512.0313

Exact Mass Matches: 512.0313

Found 61 metabolites which its exact mass value is equals to given mass value 512.0313, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

6-(Dibromomethylene)-17beta-hydroxy-androst-4-en-3-one propionate

C23H30Br2O3 (512.0562)

Cefamandole nafate

C19H17N6NaO6S2 (512.0549)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

{2-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-6-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl}oxidanesulfonic acid

C21H20O13S (512.0625)

{2-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-8-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl}oxidanesulfonic acid

C21H20O13S (512.0625)

Vitexin 7-O-sulfate

C21H20O13S (512.0625)

Isovitexin 7-O-sulfate

5,7,4-Trihydroxyflavone 6-C-glucoside 7-O-sulfate

C21H20O13S (512.0625)

3,5,7-Trihydroxyflavone 3-glucoside-8-sulfate

3- (beta-D-Glucopyranosyloxy) -5,7-dihydroxy-4-oxo-2-phenyl-4H-1-benzopyran-8-sulfonic acid

C21H20O13S (512.0625)

Galangin 3-O-beta-D-glucoside-8-sulfonate

(-)-Galangin 3-O-beta-D-glucoside-8-sulfonate

C21H20O13S (512.0625)

7-(3,5-dihydroxyphenoxy)-3-(2,4,6-trihydroxyphenoxy)dibenzo-p-dioxin-1,2,6,8-tetrol

C24H16O13 (512.0591)

alpha-Oxo-2,4,6-trihydroxy-3-[2-(3,4-dihydroxyphenyl)-4-oxo-5,7-dihydroxy-2,3-epoxy-3,4-dihydro-2H-1-benzopyran-3-yl]benzeneacetic acid methyl ester

C24H16O13 (512.0591)

T988|T988 A|T988A

C23H20N4O4S3 (512.0647)

PU-H71

9H-Purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-

C18H21IN6O2S (512.0491)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents

Arbidol HCl

C22H26BrClN2O3S (512.0536)

Tris(1,1,1,3,3,3-hexafluoro-2-propanyl) borate

C9H3BF18O3 (511.9888)

bis-(2,4,6-Trimethylpyridine)iodine(I) hexafluorophosphate

C16H20F6IN2P (512.0313)

Tris(perfluorophenyl)borane

C18BF15 (511.9854)

2-amino-6-(4-chlorophenyl)sulfanyl-4-[1-[(2R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-5-yl]pyridine-3,5-dicarbonitrile

C22H17ClN6O5S (512.067)

Cromolyn sodium

Cromolyn (sodium)

C23H14Na2O11 (512.0331)

C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C29714 - Mast Cell Stabilizer COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000893 - Anti-Inflammatory Agents > D000082142 - Mast Cell Stabilizers D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D018926 - Anti-Allergic Agents D007155 - Immunologic Factors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

3-(Perfluoro-5-methylhexyl)-2-hydroxypropyl methacrylate

C14H11F15O3 (512.0469)

Ponceau SS

C22H16N4O7S2 (512.046)

5-Chloro-4-((1-(5-chloro-2-pyrimidinyl)-4-piperidinyl)oxy)-1-(2-fluoro-4-(methylsulfonyl)phenyl)-2(1H)-pyridinone

C21H19Cl2FN4O4S (512.0488)

C.I. Acid Red 73, disodium salt

C22H16N4O7S2 (512.046)

Ethyl uridine triphosphate

C11H19N2O15P3 (511.9998)

2,2-Azino-bis-(3-ethylbenzothiazoline-6-sulfonate)

C18H16N4O6S4-2 (511.9953)

D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents

L-lactyl-2-diphospho-5-guanosine(3-)

C13H16N5O13P2-3 (512.022)

dTDP-4-dehydro-2,3,6-trideoxy-alpha-D-hexopyranose

C16H22N2O13P2-2 (512.0597)

5-O-{[(1S)-1-carboxylatoethoxy]phosphinato}-1-deoxy-1-(8-hydroxy-2,4-dioxo-2H-pyrimido[4,5-b]quinolin-3-id-10(4H)-yl)-D-ribitol

C19H19N3O12P-3 (512.0706)

3-ADP-glycerate(3-)

C13H16N5O13P2-3 (512.022)

ABTS radical cation

C18H16N4O6S4- (511.9953)

3-D-glucosyluronate-N2-,6-disulo-beta-D-glucosamine

C12H18NO17S2-3 (512.0016)

OG-514 dye

C22H9F5O7S (511.9989)

D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins

2-[(2-Hydroxynaphthalen-1-yl)diazenyl]-5-[(4-sulfophenyl)diazenyl]benzene-1-sulfonic acid

C22H16N4O7S2 (512.046)

N-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-5-methyl-N-(thiophen-2-ylmethyl)-2,1,3-benzothiadiazole-4-sulfonamide

C23H20N4O4S3 (512.0647)

N-[1-benzyl-2,4,6-trioxo-5-(trifluoromethyl)-2,3,4,5,6,7-hexahydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl]-2,4-dichlorobenzamide

C21H13Cl2F3N4O4 (512.0266)

3-D-glucuronosyl-N(2),6-disulfonato-beta-D-glucosamine(3-)

C12H18NO17S2-3 (512.0016)

ustilaginoidin A dianion

C28H16O10-2 (512.0743)

(4-{(E)-[5-(4-chlorophenyl)-6-(ethoxycarbonyl)-7-methyl-3-oxo-5H-[1,3]thiazolo[3,2-a]pyrimidin-2(3H)-ylidene]methyl}phenoxy)acetic acid

C25H21ClN2O6S (512.0809)

N(2)-(1-hydroxy-2-oxopropyl)-GDP

C13H16N5O13P2-3 (512.022)

Cefuzonam anion

C16H14N7O5S4- (511.9939)

ustilaginoidin A(2-)

C28H16O10 (512.0743)

A phenolate anion that is the conjugate base of ustilaginoidin A, obtained by deprotonation of the two hydroxy groups at positions 5 and 5. It is the major microspecies at pH 7.3.

cefuzonam(1-)

C16H14N7O5S4 (511.9939)

The monocarboxylic acid anion formed by deprotonating cefuzonam at the carboxyl oxygen.

dTDP-4-dehydro-2,3,6-trideoxy-alpha-D-glucose(2-)

C16H22N2O13P2 (512.0597)

A nucleotide-sugar oxoanion arising from deprotonation of the diphosphate OH groups of dTDP-4-dehydro-2,3,6-trideoxy-alpha-D-glucose; major species at pH 7.3.

GSK-25

C24H16Cl2F2N6O (512.0731)

GSK-25 is a potent, selective and orally bioavailable ROCK1 inhibitor (IC50=7 nM). GSK-25 maintains good selectivity against a panel of 31 kinases (>100 fold), as well as RSK1 and p70S6K (RSK1: IC50=398 nM, p70S6K: IC50=1 μM). GSK-25 inhibits P450 profile (IC50s of 2.5, 5.2, 2.5 μM for CYP2C9, CYP2D6, CYP3A4, respectively)[1].